Abstract
The diagnostic approach for pancreatic disease must rely on a combination of laboratory tests, imaging studies, and clinical symptoms. However, the symptoms of pancreatic diseases are often absent for a long time. Establishing a diagnosis at an early stage of the disease can improve outcomes by providing adequate treatment modalities and preventing complications. Pancreatic enzyme tests in body fluids have proven their value in evaluation of pancreatic disease but have some limitations. Pancreatic function tests detect diffuse pancreatic disease and reveal early deterioration of pancreatic exocrine function before the clinical characteristics such as maldigestion or steatorrhea occur. Advances in technologies have given the ability to visualize changes in pancreatic structure using available imaging procedures. However, detecting pancreatic disease in its early stages is still a difficult task. In this chapter, we discuss the diagnostic approach to pancreatic disease, and the advantages and disadvantages of available diagnostic methods, identifying gaps for each method to increase diagnostic accuracy of early-stage pancreatic disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer. Gut. 2007;56:1134–52.
Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med. 2016;375(20):1972–81.
Issa Y, et al. Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study. HPB. 2017;19:978. https://doi.org/10.1016/j.hpb.2017.07.006.
Anaizi A, Hart PA, Conwell DL. Diagnosing chronic pancreatitis. Dig Dis Sci. 2017;62:1713–20.
Ramsey ML, Conwell DL, Hart PA. Complications of chronic pancreatitis. Dig Dis Sci. 2017;62(7):1745–50.
Fonseca V, Berger LA, Beckett AG, Dandona P. Size of pancreas in diabetes mellitus: a study based on ultrasound. Br Med J. 1985;291:1240–1.
Della Corte C, Mosca A, Majo F, et al. Nonalcoholic fatty pancreas disease and nonalcoholic fatty liver disease: more than ectopic fat. Clin Endocrinol. 2015;83:656–62.
Jeong HT, Lee MS, Kim MJ. Quantitative analysis of pancreatic echogenicity on transabdominal sonography: correlations with metabolic syndrome. J Clin Ultrasound. 2015;43:98–108.
Li D. Diabetes and pancreatic cancer. Mol Carcinog. 2012;51(1):64–74.
Buscarini E, Greco S. Transabdominal ultrasonography of the pancreas. In: D’Onofrio M, editor. Ultrasonography of the pancreas. Milan: Springer; 2012.
Rickes S, Unkrodt K, Neye H, Okran KW, Wermke W. Differentiation of pancreatic tumours by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography. Scand J Gastroenterol. 2002;37:1313–20.
Kitano M, Kudo M, Maekawa K, Suetomi Y, Sakamoto H, Fukuta N, et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut. 2004;53:854–9.
Park MK, Jo J, Kwon H, Cho JH. Oh JY, Noh MH, Nam KJ. Usefulness of acoustic radiation force impulse elastography in the differential diagnosis of benign and malignant solid pancreatic lesions. Ultrasonography. 2014;33:26–33.
Kawada N, Tanaka S, Uehara H, Ohkawa K, Yamai T, Takada R, Shiroeda H, Arisawa T, Tomita Y. Potential use of point shear wave elastography for the pancreas: a single center prospective study. Eur J Radiol. 2014;83:620–4.
Kawada N, Tanaka S. Elastography for the pancreas: current status and future perspective. World J Gastroenterol. 2016;22(14):3712–24.
Zamboni GA, Ambrosetti MC, D’Onofrio M, Pozzi Mucelli R. Ultrasonography of the pancreas. Radiol Clin N Am. 2012;50:395–406.
Catalano MF, Sahai A, Levy M, Romagnuolo J, Wiersema M, Brugge W, Freeman M, Yamao K, Canto M, Hernandez LV. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc. 2009;69:1251–61.
Bolondi L, Priori P, Gullo L, et al. Relationship between morphological changes detected by ultrasonography and pancreatic exocrine function in chronic pancreatitis. Pancreas. 1987;2(2):222–9.
Coté GA, Smith J, Sherman S, Kelly K. Technologies for imaging the normal and diseased pancreas. Gastroenterology. 2013;144(6):1262–71.
Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology. 2002;223(3):603–13.
Valls C, et al. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol. 2002;178:821–6.
Cassinotto C, Chong J, Zogopoulos G, Reinhold C, Chiche L, Lafourcade JP, Cuggia A, Terrebonne E, Dohan A, Gallix B. Resectable pancreatic adenocarcinoma: role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes. Eur J Radiol. 2017;90:152–8.
Sherman S, Freeman ML, Tarnasky PR, Wilcox CM, Kulkarni A, Aisen AM, Jacoby D, Kozarek RA. Administration of secretin (RG1068) increases the sensitivity of detection of duct abnormalities by magnetic resonance cholangiopancreatography in patients with pancreatitis. Gastroenterology. 2014;147(3):646–54.
Manfredi R, Pozzi Mucelli R. Secretin-enhanced MR imaging of the pancreas. Radiology. 2016;279(1):29–43.
Dimastromatteo J, Brentnall T, Kelly KA. Imaging in pancreatic disease. Nat Rev Gastroenterol Hepatol. 2017;14(2):97–109.
Sato A, Irisawa A, Bhutani MS, Shibukawa G, Yamabe A, Fujisawa M, Igarashi R, Arakawa N, Yoshida Y, Abe Y, Maki T, Hoshi K, Ohira H. Significance of normal appearance on endoscopic ultrasonography in the diagnosis of early chronic pancreatitis. Endosc Ultrasound. 2017;0:0. https://doi.org/10.4103/2303-9027.209870.
Bhutiani N, et al. Assessing the value of endoscopic ultrasound in predicting symptom severity and long-term clinical course in chronic pancreatitis. HPB. 2017;19:868. https://doi.org/10.1016/j.hpb.2017.05.012.
Storm AC, Lee LS. Endoscopic ultrasound-guided techniques for diagnosing pancreatic mass lesions: can we do better? World J Gastroenterol. 2016;22(39):8658–69.
Adler D, Schmidt CM, Al-Haddad M, Barthel JS, Ljung BM, Merchant NB, Romagnuolo J, Shaaban AM, Simeone D, Pitman MB, Layfield LJ. Clinical evaluation, imaging studies, indications for cytologic study and preprocedural requirements for duct brushing studies and pancreatic fine-needle aspiration: the Papanicolaou Society of Cytopathology Guidelines. Cytojournal. 2014;11(Suppl 1):1.
Tadic M, Stoos-Veic T, Kusec R. Endoscopic ultrasound guided fine needle aspiration and useful ancillary methods. World J Gastroenterol. 2014;20(39):14292–300.
Pitman MB, Layfield LJ. The Papanicolaou Society of Cytopathology system for reporting pancreatobiliary cytology: definitions, criteria and explanatory notes. Cham: Springer; 2015.
Layfield LJ, Ehya H, Filie AC, Hruban RH, Jhala N, Joseph L, Vielh P, Pitman MB. Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: the Papanicolaou Society of Cytopathology Guidelines. Cytojournal. 2014;11(Suppl 1):4.
Iglesias-García J, Lindkvist B, Lariño-Noia J, Domínguez-Muñoz JE. The role of EUS in relation to other imaging modalities in the differential diagnosis between mass forming chronic pancreatitis, autoimmune pancreatitis and ductal pancreatic adenocarcinoma. Rev Esp Enferm Dig. 2012;104(6):315–21.
Hollerbach S, Klamann A, Topalidis T, Schmiegel WH. Endoscopic ultrasonography (EUS) and fine-needle aspiration (FNA) cytology for diagnosis of chronic pancreatitis. Endoscopy. 2001;33(10):824–31.
Stelow EB, Bardales RH, Lai R, Mallery S, Linzie BM, Crary GS, Stanley MW. The cytological spectrum of chronic pancreatitis. Diagn Cytopathol. 2005;32(2):65–9.
Boursi B, Finkelman B, Giantonio BJ, Haynes K, Rustgi AK, Rhim AD, Mamtani R, Yang YX. A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes. Gastroenterology. 2017;152(4):840–50.
Chen J, Yang R, Lu Y, Xia Y, Zhou H. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review. J Cancer Res Clin Oncol. 2012;138(9):1433–41.
Hruban RH, Adsay NV. Molecular classification of neoplasms of the pancreas. Hum Pathol. 2009;40(5):612–23.
Yao K, Wang Q, Jia J, Zhao HA. Competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer. Tumour Biol. 2017;39(6):1010428317707882. https://doi.org/10.1177/1010428317707882.
Bellizzi AM. Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry. Adv Anat Pathol. 2013;20(5):285–314.
Mizuno S, Isayama H, Nakai Y. Prevalence of pancreatic cystic lesions is associated with diabetes mellitus and obesity: an analysis of 5296 individuals who underwent a preventive medical examination. Pancreas. 2017;46:801. https://doi.org/10.1097/MPA.0000000000000833.
Pitman MB. Pancreatic cyst fluid triage: a critical component of the preoperative evaluation of pancreatic cysts. Cancer Cytopathol. 2013;121(2):57–60.
Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, Kimura W, Levy P, Pitman MB, Schmidt CM, Shimizu M, Wolfgang CL, Yamaguchi K, Yamao K. International Association of Pancreatology. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97.
Tanaka M, Fernández-Del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T, Salvia R, Shimizu Y, Tada M, Wolfgang CL. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017. https://doi.org/10.1016/j.pan.2017.07.007.
Park WG, Mascarenhas R, Palaez-Luna M, Smyrk TC, O'Kane D, Clain JE, Levy MJ, Pearson RK, Petersen BT, Topazian MD, Vege SS, Chari ST. Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas. 2011;40(1):42–5.
Kadayifci A, Al-Haddad M, Atar M, Dewitt JM, Forcione DG, Sherman S, Casey BW, Fernandez-Del Castillo C, Schmidt CM, Pitman MB, Brugge WR. The value of KRAS mutation testing with CEA for the diagnosis of pancreatic mucinous cysts. Endosc Int Open. 2016;4(4):E391–6.
Conner JR, Mariño-Enríquez A, Mino-Kenudson M, Garcia E, Pitman MB, Sholl LM, Srivastava A, Doyle LA. Genomic characterization of low- and high-grade pancreatic mucinous cystic neoplasms reveals recurrent KRAS alterations in “high-risk” lesions. Pancreas. 2017;46(5):665–71.
Scourtas A, Dudley JC, Brugge WR, Kadayifci A, Mino-Kenudson M, Pitman MB. Preoperative characteristics and cytological features of 136 histologically confirmed pancreatic mucinous cystic neoplasms. Cancer. 2017;125(3):169–77.
Volmar KE, Vollmer RT, Routbort MJ, Creager AJ. Pancreatic and bile duct brushing cytology in 1000 cases: review of findings and comparison of preparation methods. Cancer. 2006;108(4):231–8.
Chadwick BE, Layfield LJ, Witt BL, Schmidt RL, Cox RN, Adler DG. Significance of atypia in pancreatic and bile duct brushings: follow-up analysis of the categories atypical and suspicious for malignancy. Diagn Cytopathol. 2014;42(4):285–91.
Dudley JC, Zheng Z, McDonald T, Le LP, Dias-Santagata D, Borger D, Batten J, Vernovsky K, Sweeney B, Arpin RN, Brugge WR, Forcione DG, Pitman MB, Iafrate AJ. Next-generation sequencing and fluorescence in situ hybridization have comparable performance characteristics in the analysis of Pancreaticobiliary brushings for malignancy. J Mol Diagn. 2016;18(1):124–30.
Elek G, Gyökeres T, Schäfer E, Burai M, Pintér F, Pap A. Early diagnosis of pancreatobiliary duct malignancies by brush cytology and biopsy. Pathol Oncol Res. 2005;11(3):145–55.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Tadić, M., Štoos-Veić, T., Grgurević, I. (2018). Diagnostic Approach. In: Duvnjak, M., Smirčić-Duvnjak, L. (eds) Gastrointestinal Complications of Diabetes . Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-75856-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-75856-5_18
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-75855-8
Online ISBN: 978-3-319-75856-5
eBook Packages: MedicineMedicine (R0)